Why is pharma so scared of psychiatric drug discovery?
Department of Forensic and Neurodevelopmental Sciences, The Sackler Centre for Translational Neurodevelopment, Institute of Psychiatry, Psychology & Neuroscience, King’s College London, London, UK
Biography:
Laura is currently the Programme Manager for the Psychiatry Consortium at Medicines Discovery Catapult, working with 7 Pharma partners, 2 research charities and Wellcome to create a portfolio of projects to accelerate drug discovery in psychiatric disorders.
Subjects of specialization: Psychopharmacology,Clinical Assessment,Mental illness,Psychopathology,Neuroimaging